CCR5 and CXCR4 antagonist and agonist binding sites

Eitemau Tebyg

• CCR5 and CXCR4 antagonist and agonist binding sites
  gan: Dratz Edward, et al.
  Cyhoeddwyd: (2006-12-01)
• Structural insights from binding poses of CCR2 and CCR5 with clinically important antagonists: a combined in silico study.
  gan: Gugan Kothandan, et al.
  Cyhoeddwyd: (2012-01-01)
• Filling the Gaps in Antagonist CCR5 Binding, a Retrospective and Perspective Analysis
  gan: Yerkezhan Amerzhanova, et al.
  Cyhoeddwyd: (2022-01-01)
• The predicted 3D structure of the human D2 dopamine receptor and the binding site and binding affinities for agonists and antagonists
  gan: Kalani, M. Yashar S., et al.
  Cyhoeddwyd: (2004)
• The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1
  gan: María Rosa López-Huertas, et al.
  Cyhoeddwyd: (2017-05-01)